Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1921928 | Parkinsonism & Related Disorders | 2008 | 4 Pages |
Abstract
A 61-year-old man with Parkinson's disease (PD) developed sudden-onset visual impairment after initiation of amantadine treatment. Ophthalmologic examination revealed corneal endothelial edema. Discontinuation of amantadine resulted in rapid improvement of visual acuity. A review of the literature indicated only a few reports of amantadine-associated corneal dysfunction in patients with neurological disorders as well as influenza syndrome, but none with PD. Amantadine-associated visual impairment in PD could be possibly overlooked, since PD mainly affects elderly people who often develop aging-related ocular changes. The present report alerts neurologists and physicians in general to the peculiar ophthalmologic side effect of amantadine.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Shin-ichiro Kubo, Akira Iwatake, Nobuyuki Ebihara, Akira Murakami, Nobutaka Hattori,